FDA Approves Headband to Reduce Incidence of Migraine Headaches
18 Mar, 2014 | Labroots
Relief could be available to the millions of people who suffer from migraines. The Food and Drug Administration has given their approval to the first device used in the prevention of migraines, exciting news that could seriously impact thousands of people. The device is called Cefaly and it looks a little like a headband that a super hero might wear. It runs on a battery and rests across the forehead and over the ears. A self-adhesive electrode is used to keep the device in place while it delivers an electric current to the underlying skin and body tissues to stimulate branches of the trigeminal nerve. This is the nerve that has been thought to have an association with migraine headaches.
Cefaly Technology is the Belgium-based company responsible for Cefaly, and it is available only by prescription. Its use is limited to adults who suffer from migraines and who are warned not to wear it for more than 20 minutes a day. Wearing the device may produce a tingling or massaging sensation due to the placement of the electrode.
Professionals hope that the use of Cefaly will lead to an effective treatment for those suffering from migraine headaches since it works towards stopping the headaches at the trigger level. Although there is a great deal of variation in the severity and frequency of migraines from one person to the next, a treatment could mean spending fewer days battling migraines in comparison to the consequences of using no treatment. This is truly exciting science in the news for migraine sufferers.RECENT POSTS
Tips for Successful Social Campaigns with Labroots
05 Apr, 2024
Labroots 2023 In Review
11 Jan, 2024
Labroots: 2022 In Review
21 Dec, 2022
Tips for Successful Social Campaigns with Labroots
28 Jan, 2022
2021 in Review
12 Jan, 2022
Sony Biotechnology: Virtual Summit 2021
06 Dec, 2021
